Anne Czichos/iStock Editorial via Getty Images Introduction The last time I covered Chipotle Mexican Grill, Inc. ( CMG ), I reiterated their Buy rating, highlighting their ongoing expansion and robust free cash flow despite near-term pressure on the industry and the company's decision to keep prices lower and take a hit over sacrificing their market share. Following a solid quarter, CMG remains in...
Anne Czichos/iStock Editorial via Getty Images Introduction The last time I covered Chipotle Mexican Grill, Inc. ( CMG ), I reiterated their Buy rating, highlighting their ongoing expansion and robust free cash flow despite near-term pressure on the industry and the company's decision to keep prices lower and take a hit over sacrificing their market share. Following a solid quarter, CMG remains in a great financial position, with a spotless balance sheet with zero long-term debt, ramping up its domestic and international expansion despite the ongoing macro slowdown and headwinds, with a valuation that still offers a solid margin of safety. Starting 2026 on a Strong Note Chipotle Mexican Grill IR Chipotle reported yet another strong quarter, beating the market's revenue estimates by a bit and delivering EPS in line , delivering a surprise positive (0.5%) comparable restaurant sales increase while the digital sales continued to grow well, although the margin dropped by 250 b.p. YoY due to the company's response to the environment (aiming at maintaining a strong value proposition). For 2026, CMG continues to advance on its Recipe for Growth strategy and aggressive expansion, planning on adding around 350 (previously 350 to 370) new restaurants (10 to 15 international, partner-operated), with over 80% having a Chipotlane, moving closer to its goal of reaching 7,000 units in North America and highlighting its international expansion plans as well. As part of their recent Recipe For Growth plan, they added a record 334 stores in 2025 and should deliver even more in 2026, while also advancing on their international expansion following recent partnerships in Mexico, Singapore, and South Korea (and expecting some delays in the Middle East), with the goal of reaching an 8% to 10% annual new unit growth rate. I believe that given their significant growth potential thanks to these new openings alongside potential macro improvements and shareholder returns, there is solid potent...
Option Care Health press release ( OPCH ): Q1 Non-GAAP EPS of $0.40 beats by $0.03 . Revenue of $1.35B (+1.5% Y/Y) misses by $50M . For the full year 2026, Option Care Health now expects to generate: Net revenue of $5.675 billion to $5.775 billion vs $5.94B consensus Adjusted diluted earnings per share of $1.82 to $1.92 vs $1.50 consensus Adjusted EBITDA of $480 million to $505 million Cash provid...
Option Care Health press release ( OPCH ): Q1 Non-GAAP EPS of $0.40 beats by $0.03 . Revenue of $1.35B (+1.5% Y/Y) misses by $50M . For the full year 2026, Option Care Health now expects to generate: Net revenue of $5.675 billion to $5.775 billion vs $5.94B consensus Adjusted diluted earnings per share of $1.82 to $1.92 vs $1.50 consensus Adjusted EBITDA of $480 million to $505 million Cash provided by operating activities of at least $320 million More on Option Care Health Option Care Health, Inc. (OPCH) Q4 2025 Earnings Call Transcript Option Care Health Q1 2026 Earnings Preview Most oversold mid-cap healthcare stocks on Wall Street amid Middle East disruptions Seeking Alpha’s Quant Rating on Option Care Health Historical earnings data for Option Care Health
Bonjour et Bienvenue to the Paris Edition. I’m Paris Bureau Chief Alan Katz . If you haven’t yet, subscribe now to the Paris Edition newsletter . Drinking Alone The company statement was terse — as they often are when announcing bad news. Still, real disappointment seemed to fill the spaces between the three lines of Pernod Ricard’s press release announcing the end of merger talks with the company...
Bonjour et Bienvenue to the Paris Edition. I’m Paris Bureau Chief Alan Katz . If you haven’t yet, subscribe now to the Paris Edition newsletter . Drinking Alone The company statement was terse — as they often are when announcing bad news. Still, real disappointment seemed to fill the spaces between the three lines of Pernod Ricard’s press release announcing the end of merger talks with the company that owns Jack Daniel’s whiskey. Shareholders in both Pernod Ricard and Brown-Forman, too, made clear their dismay by pushing both stocks lower. That talks foundered on a supposed “merger of equals” between two family-linked companies shouldn’t have come as a surprise. Bloomberg wrote in March about the pitfalls of getting the two founding clans whose business histories stretch back generations to loosen their hold. And even if the immediate stock hit was sharper for Brown-Forman, at least it has other suitors in the wings, namely Southern Comfort-maker Sazerac. There isn’t an immediate alternative deal waiting for Pernod. Pernod said it’s “fully focused and confident in its strategy and operating model.” But the spirits industry is going through such a dramatic shift in norms around drinking that every company in that sector will need to continue to consider whether its future lies alone or with others. The IWSR, a drinks industry research firm, said data for 21 markets and duty-free retail — collectively accounting for about 75% of the global total — shows servings of alcohol falling since 2022. Last August, a Gallup gauge of US alcohol consumption slid to the lowest since records began in 1939. For Pernod, sales fell in both fiscal 2024 and 2025, a trend that’s continued so far in 2026. Investors have taken note. A Bloomberg gauge of some 50 wine, beer and spirits companies has dropped by nearly half since peaking in June 2021. Pernod shares have done even worse, sliding more than 71% since their peak in April 2023. Pernod puts a lot of emphasis in its quarterly reports...
Vistance Networks press release ( VISN ): Q1 Non-GAAP EPS of $0.34 beats by $0.12 . Revenue of $471.8M (+21.6% Y/Y) beats by $9.95M . Non-GAAP adjusted EBITDA of $87.3 million . Core non-GAAP adjusted EBITDA of $87.3 million. Cash flow used in operations of $(226.6) million and free cash flow of $(228.8) million. Adjusted EBITDA Outlook Reconciliation Outlook Range 2026 Operating income $ 162 $ 20...
Vistance Networks press release ( VISN ): Q1 Non-GAAP EPS of $0.34 beats by $0.12 . Revenue of $471.8M (+21.6% Y/Y) beats by $9.95M . Non-GAAP adjusted EBITDA of $87.3 million . Core non-GAAP adjusted EBITDA of $87.3 million. Cash flow used in operations of $(226.6) million and free cash flow of $(228.8) million. Adjusted EBITDA Outlook Reconciliation Outlook Range 2026 Operating income $ 162 $ 205 Adjustments: Amortization of purchased intangible assets 102 102 Equity-based compensation 23 24 Restructuring costs, net and transaction and transformation costs 45 50 Depreciation 18 19 Total adjustments to operating income 188 195 Adjusted EBITDA $ 350 $ 400 Click to enlarge More on Vistance Networks Vistance Networks: What Comes After The Special Dividend (Earnings Preview) Vistance Networks Is No Longer A Cleanup Story Vistance Networks Looks Better Than Before With Powerful Earnings Growth Vistance Networks Q1 2026 Earnings Preview Vistance Networks declares $10.00 special cash dividend
"The Pulse With Francine Lacqua" is all about conversations with high profile guests in the beating heart of global business, economics, finance and politics. Based in London, we go wherever the story is, bringing you exclusive interviews and market-moving scoops. Today's guests: Sören Radde, Point72, Head of European Economic Research; Iain Stealey, JPMorgan Asset Management, Fixed Income Interna...
"The Pulse With Francine Lacqua" is all about conversations with high profile guests in the beating heart of global business, economics, finance and politics. Based in London, we go wherever the story is, bringing you exclusive interviews and market-moving scoops. Today's guests: Sören Radde, Point72, Head of European Economic Research; Iain Stealey, JPMorgan Asset Management, Fixed Income International CIO; Nive Bhagat, Capgemini CFO. (Source: Bloomberg)
Bandwidth press release ( BAND ): Q1 Non-GAAP EPS of $0.13 misses by $0.17 . Revenue of $209M (+20.1% Y/Y) beats by $7.43M . 2Q 2026Guidance Full Year 2026Guidance Revenue $214 - $220 $880 - $900 vs. $873.12M consensus Adjusted EBITDA $24 - $27 $119 - $125 Non-GAAP earnings per share (1) $0.35 - $0.37 $1.77 - $1.83 Click to enlarge Shares +24% PM. More on Bandwidth Bandwidth Inc. (BAND) Discusses ...
Bandwidth press release ( BAND ): Q1 Non-GAAP EPS of $0.13 misses by $0.17 . Revenue of $209M (+20.1% Y/Y) beats by $7.43M . 2Q 2026Guidance Full Year 2026Guidance Revenue $214 - $220 $880 - $900 vs. $873.12M consensus Adjusted EBITDA $24 - $27 $119 - $125 Non-GAAP earnings per share (1) $0.35 - $0.37 $1.77 - $1.83 Click to enlarge Shares +24% PM. More on Bandwidth Bandwidth Inc. (BAND) Discusses Strategic Positioning in Global Cloud Communications and AI-Driven Enterprise Solutions Prepared Remarks Transcript Bandwidth Inc. (BAND) Discusses Strategic Positioning in Global Cloud Communications and AI-Driven Enterprise Solutions - Slideshow Bandwidth Inc. (BAND) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript Bandwidth Q1 2026 Earnings Preview Bandwidth repurchases $100M of 2028 convertible notes, retires 2026 notes
Verano Holdings press release ( VRNO ): Q1 Revenue of $208M (-0.9% Y/Y) beats by $7.41M . Gross profit of $99 million or 48% of revenue. SG&A expenses of $86 million or 41% of revenue. Net Loss of $(18) million or (9)% of revenue. Adjusted EBITDA 1 of $49 million or 24% of revenue. Net cash provided by operating activities of $19 million. Capital expenditures of $15 million. 2026 Guidance First Qu...
Verano Holdings press release ( VRNO ): Q1 Revenue of $208M (-0.9% Y/Y) beats by $7.41M . Gross profit of $99 million or 48% of revenue. SG&A expenses of $86 million or 41% of revenue. Net Loss of $(18) million or (9)% of revenue. Adjusted EBITDA 1 of $49 million or 24% of revenue. Net cash provided by operating activities of $19 million. Capital expenditures of $15 million. 2026 Guidance First Quarter 2026 Operational Highlights The Company reiterates its 2026 capital expenditures guidance range of $30 million to $50 million. Strengthened national product portfolio in fast-growing pre-roll category with the launch of Swift Lifts as a standalone brand. Elevated Florida retail footprint with the opening MÜV Deltona and MÜV Lehigh Acres. Upsized the revolving credit facility commitment to $100,000,000 and extended maturity date to February 28, 2029. Closed on a $195,000,000 senior secured term loan and drew the remaining $50,000,000 under its existing revolving credit facility to payoff and terminate the Company’s 2022 credit facility. More on Verano Holdings Corp. Verano Is The Best Large MSO Stock Verano Holdings Needs Better Synergies To Compete With Its Peers Verano Holdings Corp. (VRNO:CA) Q4 2025 Earnings Call Transcript Verano Holdings Q1 2026 Earnings Preview Verano outlines $195M refinancing and targets growth in Texas and Virginia amid regulatory catalysts
Entegris press release ( ENTG ): Q1 Non-GAAP EPS of $0.86 beats by $0.11 . Revenue of $812M (+5.0% Y/Y) beats by $6.25M . Second Quarter of 2026 Outlook For the Company’s guidance for the second quarter ending June 27, 2026, the Company expects sales of $815 million to $845 million (vs. consensus of $827.8M). We expect GAAP net income to be between $82 million and $94 million and diluted earnings ...
Entegris press release ( ENTG ): Q1 Non-GAAP EPS of $0.86 beats by $0.11 . Revenue of $812M (+5.0% Y/Y) beats by $6.25M . Second Quarter of 2026 Outlook For the Company’s guidance for the second quarter ending June 27, 2026, the Company expects sales of $815 million to $845 million (vs. consensus of $827.8M). We expect GAAP net income to be between $82 million and $94 million and diluted earnings per common share is expected to be between $0.53 and $0.61. On a non-GAAP basis, the Company expects diluted earnings per common share to range from $0.76 to $0.84 (vs. consensus of $0.77), reflecting net income on a non-GAAP basis in the range of $116 million to $129 million. The Company also expects Adjusted EBITDA of approximately 27.0% to 28.0% of sales. More on Entegris Chasing The Catch-Up: Why The Market Is Wrong To Reward Entegris Entegris: Great Company, Gold Medal Price Entegris, Inc. (ENTG) Q4 2025 Earnings Call Transcript Entegris Q1 2026 Earnings Preview Entegris outlines sub-3.5x net leverage target and $250M CapEx for 2026 amid recovery in fab construction and advanced nodes
Treasury Secretary Scott Bessent reportedly criticized Jerome Powell's decision to stay on the board of the Federal Reserve even after he steps down as the chair. Bessent told Fox Business that the move would break a Fed tradition and that it is "highly unusual for someone who says he’s an institutionalist and cares about norms at the Fed." Powell said Wednesday he plans to remain on the central b...
Treasury Secretary Scott Bessent reportedly criticized Jerome Powell's decision to stay on the board of the Federal Reserve even after he steps down as the chair. Bessent told Fox Business that the move would break a Fed tradition and that it is "highly unusual for someone who says he’s an institutionalist and cares about norms at the Fed." Powell said Wednesday he plans to remain on the central bank’s board of governors after his term as chair ends in mid-May, citing concerns about ongoing legal challenges to the institution, including the probe into the Fed’s building renovation project. Bessent added that the move by Powell would be an insult to Kevin Warsh and Fed Governors Michelle Bowman and Christopher Waller, according to a Bloomberg report. Warsh, Bowman, and Waller were picked by President Donald Trump as Powell's successor. Warch is the leading candidate to take on the position once the Senate confirms it. Powell had declined to specify how long he would serve as a governor. “I will leave when it’s appropriate to do so,” he said, amid the investigations. Dear readers : We recognize that politics often intersects with the financial news of the day, so we invite you to click here to join the separate political discussion. More on the U.S. Economy Middle East Turmoil Fuels Inflation Fears, Testing Fed's Patience Oil Prices Advance Ahead Of What Will Likely Be Powell's Last FOMC Meeting (As Chair) JBND: Active Management Cannot Fix Structural Risk Treasury yields top 1-month high as oil prices fuel inflation fears What happens to the economy when the Social Security fund runs dry?
Spencer Platt/Getty Images News The market is starting to price in a hike by December The Federal Funds futures are now pricing almost a 12% probability of a Fed hike by December. December 2026 ( CME FedWatch ) The odds of the Fed hike increase to over 35% cumulative by March 2027, where there is a 5% probability of a 50 bpt hike. March 2027 ( CME FedWatch ) Note, before the Iran war, the market w...
Spencer Platt/Getty Images News The market is starting to price in a hike by December The Federal Funds futures are now pricing almost a 12% probability of a Fed hike by December. December 2026 ( CME FedWatch ) The odds of the Fed hike increase to over 35% cumulative by March 2027, where there is a 5% probability of a 50 bpt hike. March 2027 ( CME FedWatch ) Note, before the Iran war, the market was pricing two cuts in 2026 and policy normalization down to 3%. Now, the market is just "waking up" to pricing the hikes - the market is realizing that we might be entering an inflationary regime that requires policy tightening. The primary inflation metric is near the "red zone" What exactly forces the Fed to hike, which inflation metric? We know that the Fed's primary inflation metric is the core PCE, and the core PCE has been over the 2% target since Covid; it's currently at 3.2%. Yet, the Fed still maintains an easing bias, at least publicly. The primary inflation metric that forces the Fed to act is the market measure of inflation expectations, and the key one is the 10Y breakeven inflation. The 10Y breakeven expectations should be below 2.5% - that's generally the red line, and it points to well-anchored long-term inflation expectations. Once the 10-year breakevens sustainably breach the 2.5% level, the long-term inflation expectations start to de-anchoring - and that signals that the Fed is losing its credibility to keep inflation at the 2% target. Thus, once the 10K breakeven breaches the 2.5%, the Fed generally has to start thinking about hiking interest rates. The 10Y breakevens are currently at 2.47%, thus right below the "red line". Thus, the market is appropriately starting to price the Fed hikes. The 10Y yield ( US10Y ) just closed at 4.43%, with the 10Y TIPS yield at 1.96%, which means that the 10Y breakeven inflation is 2.47%. The chart below shows what happened in 2022: 10Y breakevens broke the 2.5% towards 3%, and that forced the Fed to start aggressively...
Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha More on Caterpillar Caterpillar: The 43x P/E Data Center Trap Caterpillar: AI-Driven Power Demand And Strong Backlog Support Continued Upside Caterpillar: The Hidden AI Infrastructure Play Wall Street Is Finally Pricing In And It's Not Too Late Caterpillar Non-GAAP EPS of $5.54 beats by $0.90, revenue of $17.4B bea...
Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha More on Caterpillar Caterpillar: The 43x P/E Data Center Trap Caterpillar: AI-Driven Power Demand And Strong Backlog Support Continued Upside Caterpillar: The Hidden AI Infrastructure Play Wall Street Is Finally Pricing In And It's Not Too Late Caterpillar Non-GAAP EPS of $5.54 beats by $0.90, revenue of $17.4B beats by $980M ProPetro inks deal for up to 2.1 GW of power generation from Caterpillar
Tom Werner/DigitalVision via Getty Images Thesis Overall, after the 1Q26 earnings release, I think it’s best to hold GE HealthCare Technologies Inc. ( GEHC ) until we see some kind of recovery in the second half of the year. The company clearly benefits from a pretty resilient demand, and they do still hold a strong $21.8 billion backlog. The innovation pipeline is also compelling, which should he...
Tom Werner/DigitalVision via Getty Images Thesis Overall, after the 1Q26 earnings release, I think it’s best to hold GE HealthCare Technologies Inc. ( GEHC ) until we see some kind of recovery in the second half of the year. The company clearly benefits from a pretty resilient demand, and they do still hold a strong $21.8 billion backlog. The innovation pipeline is also compelling, which should help support steady mid-single-digit revenue growth. However, what the market wasn’t too impressed by was that it is being offset by near-term margin pressure. There was $250 million in inflation headwinds, tariff impacts, and ongoing weakness in Patient Care Solutions. Also, management on the call seemed to mention quite a few excuses and reasons for the proposed weakness and framed a second-half margin recovery. However, I think much of that relies on pricing actions that lag due to backlog dynamics, which then introduces some execution risk. The good news is that the stock is already trading at a discount at about 13x to 14x forward earnings, so I think the valuation would fairly reflect both the upside from recovery and the downside from the upcoming cost volatility. It leaves a balanced risk/reward for now. GE HealthCare Technologies Inc. 1Q26 earnings review Coming now to GE HealthCare’s results. I thought the 1Q26 readout was a bit mixed but not as bad as the market reaction would imply, as I’ll explain. We saw some solid revenue growth, but it was offset by clear pressure on profitability. Total revenue managed to rise about 7.4% year over year to $5.1 billion, which was supported by about 2.9% organic growth, which, for me, is an indicator that underlying demand is still there even after stripping out their currency/acquisition effects. Growth was actually particularly strong in their Pharmaceutical Diagnostics segment, which was up about 21.7% on a reported basis and 9.7% on an organic basis. Elsewhere, we saw some steady gains in Imaging and Advanced Visualisation ...
Defense secretary to be quizzed in Senate as Khamenei says foreigners have no place in Gulf ‘except at bottom of its waters’ Sign up for the Breaking News US email The US government’s effort to renew its warrantless domestic surveillance powers cleared the House of Representatives on Wednesday, after House speaker Mike Johnson and Trump administration officials persuaded Republican holdouts to bac...
Defense secretary to be quizzed in Senate as Khamenei says foreigners have no place in Gulf ‘except at bottom of its waters’ Sign up for the Breaking News US email The US government’s effort to renew its warrantless domestic surveillance powers cleared the House of Representatives on Wednesday, after House speaker Mike Johnson and Trump administration officials persuaded Republican holdouts to back the bill. The renewal of the Foreign Intelligence Surveillance Act now goes to the Senate, where it faces a potentially rough reception because it was attached to unrelated legislation that would restrict the Federal Reserve’s ability to issue digital currency - something Senate majority leader John Thune has described as a non-starter. Continue reading...
jetcityimage/iStock Editorial via Getty Images Shares of Eli Lilly ( LLY ) added ~6% in the premarket on Thursday after the Indiana-based pharma giant raised its full-year outlook alongside better-than-expected Q1 2026 financials driven by its GLP-1 franchise. Novo Nordisk ( NVO ), its rival in the obesity market, traded ~2% higher. The company reported $19.8B in revenue for the quarter, indicatin...
jetcityimage/iStock Editorial via Getty Images Shares of Eli Lilly ( LLY ) added ~6% in the premarket on Thursday after the Indiana-based pharma giant raised its full-year outlook alongside better-than-expected Q1 2026 financials driven by its GLP-1 franchise. Novo Nordisk ( NVO ), its rival in the obesity market, traded ~2% higher. The company reported $19.8B in revenue for the quarter, indicating ~56% YoY growth exceeding the consensus by $2B as volume gains offset the impact from lower prices for its GLP-1 products Mounjaro and Zepbound. Mounjaro added $8.7B to the topline with ~125% YoY growth, beating the $7.21B projected by analysts, according to Bloomberg data, and Zepbound generated $4.2B with ~80% YoY growth. Lilly’s ( LLY ) diabetes therapy Trulicity brought in $919M compared to $884.4M in the consensus, while Alzheimer’s therapy Kisunla added $124M compared to $22M in the prior year period. CEO David Ricks touted the company’s oral weight loss therapy, Foundayo, launched earlier this month, which rivals Novo’s ( NVO ) Wegovy pill. “Foundayo will meaningfully expand the number of people who can benefit from GLP-1s,” Ricks said. As for the bottom line, the company recorded $8.55 of adjusted earnings per share, indicating ~156% YoY growth and beating the consensus by $1.76, while its non-GAAP gross margin slipped 90 bps to 82.6%, mainly due to lower realized prices. Looking ahead, LLY projects $82.0B - $85.0B in revenue and $35.50 - $37.00 of non-GAAP EPS for 2026 compared to $80B - $83B and $33.50 - $35.00 previously, while consensus estimates indicated $81.85B of revenue and $34.53 of EPS for the company this year. Commenting on the results, Seeking Alpha analyst Edmund Ingham , Investing Group Leader for Haggerston BioHealth, said that Eli Lilly ( LLY ) is poised to return to its $1B market capitalization, and its diabetes therapy Mounjaro could become the world’s best-selling medicine. “The world's most valuable Pharma flirted with a >$1 trillion dollar ...
Broadridge Financial Solutions press release ( BR ): Q3 Non-GAAP EPS of $2.72 beats by $0.12 . Revenue of $1.95B (+7.7% Y/Y) beats by $50M . Recurring revenues increased $84 million, or 7%, to $1,288 million. Recurring revenue growth constant currency (Non-GAAP) was 6%, driven by organic growth in Investor Communication Solutions ("ICS") and Global Technology and Operations ("GTO") and acquisition...
Broadridge Financial Solutions press release ( BR ): Q3 Non-GAAP EPS of $2.72 beats by $0.12 . Revenue of $1.95B (+7.7% Y/Y) beats by $50M . Recurring revenues increased $84 million, or 7%, to $1,288 million. Recurring revenue growth constant currency (Non-GAAP) was 6%, driven by organic growth in Investor Communication Solutions ("ICS") and Global Technology and Operations ("GTO") and acquisitions in ICS. Event-driven revenues increased $20 million, or 38%, to $73 million, from a combination of higher mutual fund proxy revenues and higher equity and other revenues. Distribution revenues increased $38 million, or 7%, to $593 million, driven primarily by the postage rate increase of approximately $34 million. Fiscal Year 2026 Financial Guidance FY'26 Guidance Updates Recurring revenue growth constant currency (Non-GAAP) At or above 7% Raised from higher endof 5 - 7% Adjusted Operating income margin (Non-GAAP) 20 - 21% No Change Adjusted Earnings per share growth (Non-GAAP) 10 - 12% Raised from 9 - 12% Closed sales $240 - $290M Revised from $290 -$330M Click to enlarge More on Broadridge Financial Solutions Broadridge Financial Solutions, Inc. (BR) Presents at Wolfe Research FinTech Forum Transcript Broadridge: The SaaS Apocalypse Has Created An Entry Point Broadridge Financial Solutions, Inc. (BR) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript Broadridge Financial Solutions Q3 2026 Earnings Preview Broadridge makes minority investment in Centrl, terms undisclosed
MF3d/E+ via Getty Images Shares of Check Point Software Technologies ( CHKP ) fell about 10% premarket on Thursday after mixed first quarter results. Q1 Metrics Revenue for the first quarter, ended March 31, rose about 5% year-over-year to $668M, missing estimates. Meanwhile, non-GAAP EPS surged 13% year-over-year to $2.50, beating analysts' expectations. "Subscription revenue remained a key stren...
MF3d/E+ via Getty Images Shares of Check Point Software Technologies ( CHKP ) fell about 10% premarket on Thursday after mixed first quarter results. Q1 Metrics Revenue for the first quarter, ended March 31, rose about 5% year-over-year to $668M, missing estimates. Meanwhile, non-GAAP EPS surged 13% year-over-year to $2.50, beating analysts' expectations. "Subscription revenue remained a key strength, supported by strong demand across our emerging technologies, including email security, exposure management, and SASE. Product revenue was impacted by go-to-market changes implemented at the beginning of the quarter, which created near-term headwinds in our security appliance business. We remain confident these go-to-market changes together with our market-leading technology will drive sustainable long-term value," said CEO Nadav Zafrir. Remaining Performance Obligation, or RPO, was about $2.6B, a 7% increase year over year. Revenue from Products and Licenses fell 2.8% year-over-year to $110.8M, while Security Subscriptions revenues climbed 11.2% year-on-year to $323.2M. Software updates and maintenance revenue grew about 0.5% to $234.4M. Check Point said it has appointed Sherif Seddik as chief revenue officer, effective May 1. Seddik will succeed Itai Greenberg, who is stepping down from the role. Seddik has served as the company's president of International Sales since 2023. Related stocks: Fortinet ( FTNT ) fell about 2%, while CrowdStrike ( CRWD ) and Zscaler ( ZS ) dipped nearly 1%. Cloudflare ( NET ) was also in the red premarket on Thursday. More on Check Point Software Check Point: Market Prices Stagnation, But Partial Transition Can Drive Upside Check Point Software: Market Reaction Looks Overdone Relative To Fundamentals Check Point: The Outlook For An Elite Firewall Check Point Software Technologies givs mixed Q1 performance Check Point Software Technologies Q1 2026 Earnings Preview
NovoCure press release ( NVCR ): Q1 GAAP EPS of -$0.62 misses by $0.11 . Revenue of $174.1M (+12.3% Y/Y) beats by $6.33M . Adjusted EBITDA* for the quarter was $(0.3) million. Cash, cash equivalents and short-term investments were $432.0 million as of March 31, 2026. 2026 Financial Guidance: Novocure’s updated guidance for the full year 2026, as of April 30, 2026, is summarized below: Total net re...
NovoCure press release ( NVCR ): Q1 GAAP EPS of -$0.62 misses by $0.11 . Revenue of $174.1M (+12.3% Y/Y) beats by $6.33M . Adjusted EBITDA* for the quarter was $(0.3) million. Cash, cash equivalents and short-term investments were $432.0 million as of March 31, 2026. 2026 Financial Guidance: Novocure’s updated guidance for the full year 2026, as of April 30, 2026, is summarized below: Total net revenue: $690 million - $710 million (previous: $675 million - $705 million) vs. $694.68M consensus Adjusted EBITDA*: $(15) million - $0 million (previous: $(20) million - $0 million) Operational updates for quarter ended March 31, 2026: As of March 31, 2026, there were 4,791 total active patients on TTFields therapy globally. Optune Gio As of March 31, 2026, there were 4,543 active patients on Optune Gio, an increase of 9% from the same period in 2025. The U.S., Germany, France and Japan contributed 2,250; 641; 503 and 535 Optune Gio active patients, respectively, with 614 active patients contributed by other active markets. Optune Lua As of March 31, 2026, there were 165 active patients on Optune Lua, an increase of 56% from the same period in 2025. The U.S., Germany, France and Japan contributed 106; 47; 2 and 6 active patients, respectively, with 4 active patients contributed by other active markets. Optune Pax 169 prescriptions for Optune Pax were received in the quarter. As of March 31, 2026, there were 83 active patients on Optune Pax in the U.S. More on NovoCure NovoCure Limited 2025 Q4 - Results - Earnings Call Presentation NovoCure Limited (NVCR) Q4 2025 Earnings Call Transcript NovoCure: FDA Approval For PC Unlocked With TTFields Expansion Opportunity Approaching NovoCure Q1 2026 Earnings Preview Novocure mid-stage trial for electric fields device succeeds in pancreatic cancer
(RTTNews) - Thursday, Verano Holdings Corp. (VRNO) announced that its Board of Directors has authorized the repurchase of upto $20 million in shares of the company's common stock listed on Cboe Canada.
(RTTNews) - Thursday, Verano Holdings Corp. (VRNO) announced that its Board of Directors has authorized the repurchase of upto $20 million in shares of the company's common stock listed on Cboe Canada.
OpenAI is preparing to launch a new frontier cybersecurity model, GPT-5.5-Cyber. CEO Sam Altman said the model will not be available to the general public, but will be first rolled out to a select group of trusted "cyber defenders" in order for institutions to shore up their cyberdefenses. The limited rollout will take place "in the next few days," Altman said on X . "We will work with the entire ...
OpenAI is preparing to launch a new frontier cybersecurity model, GPT-5.5-Cyber. CEO Sam Altman said the model will not be available to the general public, but will be first rolled out to a select group of trusted "cyber defenders" in order for institutions to shore up their cyberdefenses. The limited rollout will take place "in the next few days," Altman said on X . "We will work with the entire ecosystem and the government to figure out trusted access for Cyber." It's not clear who will get access to the model first, though previous "trusted access" schemes involved vetted professionals and institutions. Details of the model and its capa … Read the full story at The Verge.
(RTTNews) - While reporting financial results for the first quarter on Thursday, drugmaker Eli Lilly and Co. (LLY) raised its earnings, adjusted earnings and revenue guidance for the full-year 2026, reflecting the strong revenue performance in the first quarter.
(RTTNews) - While reporting financial results for the first quarter on Thursday, drugmaker Eli Lilly and Co. (LLY) raised its earnings, adjusted earnings and revenue guidance for the full-year 2026, reflecting the strong revenue performance in the first quarter.
ConocoPhillips press release ( COP ): Q1 Non-GAAP EPS of $1.89 beats by $0.20 . For the second quarter, the company is excluding Qatar from production guidance, given uncertainty surrounding the conflict in the Middle East . Second-quarter production is expected to be 2.185 to 2.215 million barrels of oil equivalent per day (MMBOED). Full-year production is expected to be 2.295 to 2.325 MMBOED. Th...
ConocoPhillips press release ( COP ): Q1 Non-GAAP EPS of $1.89 beats by $0.20 . For the second quarter, the company is excluding Qatar from production guidance, given uncertainty surrounding the conflict in the Middle East . Second-quarter production is expected to be 2.185 to 2.215 million barrels of oil equivalent per day (MMBOED). Full-year production is expected to be 2.295 to 2.325 MMBOED. This reflects a 20 MBOED annual adjustment for Qatar , given the exclusion of Qatar production from second-quarter guidance, as well as a 15 MBOED annual royalty rate adjustment at Surmont due to higher oil prices. Capital spending for 2026 is expected to be $12 to $12.5 billion, including incremental Permian activity. The range reflects uncertainty around the macro environment and North Field East and North Field South capital timing in Qatar . More on ConocoPhillips ConocoPhillips: A Defensive Play In The Oil Sector, But Unlikely To Beat The Market ConocoPhillips: Iran War To Be A Major Profit Catalyst ConocoPhillips: Regional Constraints May Impact Long-Term Plan, Growth Remains Ahead Navigating the blockade: Phillips 66, Valero, and ConocoPhillips face Q1 test amid global supply shocks ISS says ConocoPhillips shareholders should vote for independent board chair
Trent Alexander-Arnold has gone, Andy Robertson and Mo Salah are going, and Alisson and Virgil van Dijk may soon follow By Opta Analyst Liverpool have had some fantastic players and enjoyed plenty of success in the last decade. In recent years, they have gradually said goodbye to Georginio Wijnaldum, James Milner, Jordan Henderson, Fabinho, Sadio Mané and Roberto Firmino, but they have also retain...
Trent Alexander-Arnold has gone, Andy Robertson and Mo Salah are going, and Alisson and Virgil van Dijk may soon follow By Opta Analyst Liverpool have had some fantastic players and enjoyed plenty of success in the last decade. In recent years, they have gradually said goodbye to Georginio Wijnaldum, James Milner, Jordan Henderson, Fabinho, Sadio Mané and Roberto Firmino, but they have also retained a number of their established stars. Alisson, Trent Alexander-Arnold, Virgil van Dijk, Andy Robertson and Mohamed Salah would all be in the conversation when it comes to selecting an all-time Liverpool XI. That is quite the achievement considering the club’s rich heritage and, as recently as last season, all five were still at the club as Liverpool strolled to the Premier League title. Continue reading...